Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Wegovy needle is very short and very fine — typically 4–5 mm long and 29–32 gauge — designed specifically for subcutaneous injection just beneath the skin rather than into muscle. Most people are surprised by how small it is in practice. Wegovy is a prescription-only medicine, so before starting treatment a prescriber must confirm it's clinically suitable for you. Here's exactly what to expect from the needle itself, step by step.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Gauge describes how narrow a needle is. At 29–32 gauge, the Wegovy needle is comparable to the needles used for insulin pens, among the thinnest available for self-injection. A higher gauge number means a narrower bore, so 32 gauge is finer than 29. Length sits at 4–5 mm. For context, a standard blood-draw needle is typically around 21 gauge and far longer; the Wegovy needle is a different category entirely.
The reason the needle can be so short is that subcutaneous tissue (the layer of fat beneath the skin) sits only a few millimetres below the surface at the recommended injection sites. A longer needle would risk going too deep, into muscle, where absorption differs and discomfort tends to be greater. Short and fine is the clinically deliberate choice here, not a compromise.
If you're already curious about what patients report actually feeling, the accounts of what the Wegovy needle feels like in practice may be a useful next read, the physical experience is often more muted than people expect.
The pre-filled Wegovy pen is designed so you never need to handle the needle directly. A rigid needle cap sits over it before use; once removed, the needle tip is exposed only briefly during the injection itself. After you press the pen against your skin and press the injection button, the dose delivers automatically.
One practical note: the pen also has an inner needle cap beneath the rigid outer cap. Both need to come off before injecting, the Patient Information Leaflet inside the box walks through this in illustrated steps, and your prescriber or pharmacist can run through the sequence with you. For a close look at the physical attachment process, the guide on how to attach the needle to a Wegovy pen covers this in detail.
Because the pen locks after use and the needle retracts into the housing, accidental needle-stick risk is low. Dispose of used pens in an approved sharps container, a 1-litre sharps container fits neatly at home and complies with NHS disposal guidance.
Semaglutide (the active ingredient in Wegovy) is absorbed through subcutaneous tissue, so site selection matters more than many beginners realise. The three licensed options are the abdomen (at least 5 cm from the navel), the front or outer thigh, and the outer upper arm. Each works because subcutaneous fat is reliably accessible at these points.
Rotation is the discipline that keeps skin healthy over the weeks and months of weekly injections. Reusing the exact same spot repeatedly can cause lipohypertrophy, a lumpiness under the skin that actually slows absorption of the medicine. The practical approach: divide each site into a grid of small areas, moving to an adjacent square each week before cycling back. You can switch between sites too (abdomen one week, thigh the next) as long as you're not repeating an identical spot within a month.
Wondering whether a shorter or longer needle would suit your body type better? The overview of Wegovy needle length options covers the specifics of which needle length is recommended for different tissue depths.
Honestly, most people report very little. At 4–5 mm and 29–32 gauge, the physical intrusion is tiny, and subcutaneous tissue has fewer pain receptors than muscle. Speed of injection and skin temperature both play a small part, cold skin straight from the fridge feels slightly sharper, so allowing the pen a few minutes at room temperature first (without exceeding the storage window listed in your leaflet) is a common practical tip. The pain and sensation guide for Wegovy pulls together what most patients describe across the titration schedule.
Nausea and other gastrointestinal symptoms are the side effects most associated with Wegovy; needle-related discomfort is rarely the reason someone contacts our aftercare team. The full Wegovy guide covers the side-effect profile and what to expect during the titration schedule, and the Wegovy needle overview sits alongside it if you want a quick reference on needle specifics.
If you're comparing injectable treatments and wondering how Wegovy fits into the broader picture of weight-loss options available in the UK, that page brings together the licensed choices. Treatment costs are one factor, a fair look at what private semaglutide typically costs is laid out on the Wegovy price comparison page. Worth checking before committing to any provider. And if you're ready to find out whether Wegovy is clinically suitable for you, starting a free consultation with our prescribers takes a few minutes, order by 12pm on a working day and, once approved, your treatment goes out the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.